Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry

@article{vandenHurk2012ScalpCF,
  title={Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling Registry},
  author={Corina J G van den Hurk and Mijke Peerbooms and Lonneke V. van de Poll-Franse and Johan W. R. Nortier and Jan Willem Coebergh and Wim P. M. Breed},
  journal={Acta Oncologica},
  year={2012},
  volume={51},
  pages={497 - 504}
}
Abstract Background. Chemotherapy-induced alopecia is a frequently occurring side effect of cancer treatment with a high psychological impact which can be prevented by scalp cooling. With this multi-centre patient series we estimated the results of scalp cooling for currently used chemotherapies to provide patient information and we identified characteristics associated with the results. Material and methods. The Dutch Scalp Cooling Registry collected data on scalp-cooled patients in 28 Dutch… 
View on Taylor & Francis
paxman.com.br
95 Citations
Highly Influential Citations
5
Background Citations
32
Methods Citations
7
Results Citations
9

95 Citations

Citation Type

Citation Type

Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
Safety and effectiveness of scalp cooling in cancer patients undergoing cytotoxic treatment
TLDR
All patients facing severe alopecia should receive patient-tailored information about the possibility, effectiveness, possible side-effects and potential risk of scalp cooling in order to make an informed treatment decision.
Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia
TLDR
A 45-min post-infusion cooling times (PICT) can be recommended in 3-weekly docetaxel regimens with a dose of 75 or 100 mg/m2, administered in 60 min, which is a major advantage in time investment for patients.
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer
TLDR
Among women undergoing non–anthracycline-based adjuvant chemotherapy for early-stage breast cancer, the use of scalp cooling vs no scalp cooling was associated with less hair loss at 4 weeks after the last dose of chemotherapy, and quality of life measures were significantly better 1 month after the end of chemotherapy in the scalp cooling group.
Management of Chemotherapy-Induced Alopecia With Scalp Cooling.
TLDR
Evidence supporting the efficacy and safety of scalp cooling in preventing chemotherapy-induced alopecia in patients receiving chemotherapy for solid tumor malignancies is added and available data suggest that this technology is most effective for taxane-based chemotherapy regimens compared with anthracycline-based cancer regimens.
Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.
TLDR
The effectiveness of scalp cooling for hair preservation depends on dose and type of chemotherapy, with less favorable results at higher doses, and probably by the degree and duration of cooling.
Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia
TLDR
For the Dutch, scalp cooling was cost-effective, therefore justifying the choice of scalp cooling or purchasing a wig or head cover, and given the right indication, cost-effectiveness might be improved further by postponing wig and head cover purchases and by improving scalp cooling efficacy.
Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer.
Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study
TLDR
The use of a scalp-cooling device prevented alopecia with acceptable safety for Japanese patients and resulted in faster recovery of hair volume after chemotherapy, even in patients for whom scalp cooling failed to prevent chemotherapy-induced alopECia.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia
TLDR
A 45-min post-infusion cooling times (PICT) can be recommended in 3-weekly docetaxel regimens with a dose of 75 or 100 mg/m2, administered in 60 min, which is a major advantage in time investment for patients.
Scalp metastases and scalp cooling for chemotherapy-induced alopecia prevention.
TLDR
The incidence of scalp metastases in patients using scalp cooling methods during chemotherapy is low and it does not seem to influence the clinical outcome; however, safe conclusions regarding the impact in overall survival can be made only through a well-designed randomised trial.
Prevention of chemotherapy-induced hair loss by scalp cooling.
  • E. Grevelman, W. Breed
  • Medicine
    Annals of oncology : official journal of the European Society for Medical Oncology
  • 2005
TLDR
Scalp cooling is effective but not for all chemotherapy patients, and should not be used if chemotherapy is given with a curative intent in patients with generalised haematogenic metastases.
Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
TLDR
Concerns about the protection of malignant cells in the scalp skin by scalp cooling have been proven to be exaggerated and, up to now, scalp cooling is by far the best method to reduce CIA.
The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel.
TLDR
Significantly greater hair loss was apparent in the control group during most of the treatment period, however, the level of protection afforded by the cool caps was relatively poor with this chemotherapy combination.
Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy.
TLDR
A penguin cap can be an effective method to avoid alopecia in patients receiving chemotherapy drugs, however, it is important to bear in mind that because of individual characteristics, liver function and drug regimens it is not successful in all cases.
The Effectiveness of a Scalp Cooling Cap in Preventing Chemotherapy-Induced Alopecia
TLDR
This study shows that all the patient groups studied gained some benefit by using scalp cooling caps, and major hair loss was avoided in all patients given doxorubicin treatment.
A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.
  • Carolyn S Massey
  • Medicine
    European journal of oncology nursing : the official journal of European Oncology Nursing Society
  • 2004
Modelling physiological and biochemical aspects of scalp cooling
Chemotherapy induced hair loss is a feared side effect of cancer treatment. Scalp cooling during the administration of cytotoxic drugs can reduce this hair loss. Cooling can be achieved by means of a…
Chemotherapy-induced hair loss
TLDR
CIA prevention comprises attempts of using pharmacological agents and mechanical strategies, however scalp cooling is the only effective method until now and it is cost-effective compared to purchasing wigs and head covers.
...
1
2
3
4
5
...